For a quarter of a century, the prenatal sex steroid theory of autism has intrigued scientists and clinicians, shedding light on some of the most perplexing aspects of neurodevelopmental differences. Conceived in the late 20th century, this theory sought to explain why autism is diagnosed far more frequently in males than females and why individuals with autism often exhibit cognitive traits traditionally viewed as “male-typical,” including distinct patterns in empathizing and systemizing. Now, 25 years later, a comprehensive review in Nature Human Behaviour revisits these early insights, unveiling how far the science has come and pointing toward exciting new directions fueled by advances in genetics and stem cell biology.
At the heart of the theory lies the influence of prenatal sex steroids—hormones such as testosterone and estrogens—that sculpt the developing brain in utero. Autism spectrum conditions have long puzzled scientists because they do not fit neatly into a single causative mold; instead, they arise from a complex interplay of genetic, environmental, and hormonal factors. The initial observations highlighted not only the disproportionate prevalence among males but also cognitive differences along the empathy-systemizing axis, where individuals with autism often show enhanced systemizing abilities alongside impaired empathizing. This cognitive framework suggested a biological underpinning linked to sex hormone exposure before birth.
Early investigations provided compelling evidence correlating elevated levels of prenatal testosterone with slower development in social communication, reduced language acquisition, and diminished empathic responses. Intriguingly, these studies also noted an increased focus on details and stronger systemizing tendencies—traits frequently reported in autistic individuals. These findings opened doors to a hormone-focused model of autism etiology that challenged traditional thinking centered largely on post-birth environmental influences or singular genetic determinants.
Subsequent research expanded the hormonal landscape, revealing that estrogens—often overlooked in neurodevelopmental studies—also play a critical role. Both prenatal androgens and estrogens appear to contribute to neurodevelopmental trajectories that manifest as autism spectrum behaviors. This nuanced understanding highlighted that it is not merely the presence of testosterone but the complex balance and timing of multiple sex steroids during critical periods of neural development that shape outcomes. This broadened hormonal perspective urges a reassessment of how we conceptualize the biological pathways leading to autism.
In pioneering work utilizing genetic methodologies, researchers identified genes regulating sex steroid production and signaling pathways that show atypical patterns in autism. These genetic insights reinforce the hormonal theory, suggesting that inherited variations affecting hormone synthesis, receptor sensitivity, or downstream signaling cascades could predispose individuals to autism. Such discoveries offer promising avenues for therapeutic intervention, targeting specific molecular pathways influenced by prenatal hormonal milieu.
Stem-cell-derived neural organoids have revolutionized the study of human brain development, allowing scientists to recapitulate aspects of prenatal neurogenesis in laboratory conditions. These miniature, three-dimensional brain-like structures have provided direct evidence that sex steroids modulate neuronal proliferation, differentiation, and synapse formation in ways consistent with the prenatal sex steroid theory. Notably, organoids derived from individuals with autism exhibit hormone-dependent differences, underscoring that atypical steroid hormone signaling may shape neural circuitry from the earliest stages of brain formation.
This convergent evidence from endocrinology, genetics, and cutting-edge neuroscience has galvanized a renaissance in autism research, illuminating how prenatal sex steroids contribute to both typical and atypical brain development. Insights garnered here are not merely academic; they bear potential clinical significance. Understanding the hormonal underpinnings of autism could guide the timing and nature of early interventions, perhaps even informing prenatal care practices in the future.
Moreover, the research underscores a broader principle about sex differences in brain development, challenging simplistic binaries and emphasizing a spectrum of influence exerted by multiple interacting factors. This complexity demands that future studies incorporate diverse populations, longitudinal designs, and multi-modal analyses to unravel how sex steroids interplay with environmental stressors and genetic variation to produce the wide range of autism phenotypes.
In revisiting the original observations, the review also critically examines previous limitations, such as variability in methodologies for measuring prenatal hormones and challenges in linking hormone levels to later behaviors. Advances in non-invasive hormone measurement and longitudinal cohort studies have begun to resolve these issues, allowing for more robust and replicable findings. The field is moving toward a refined understanding of critical windows when hormonal exposures are most impactful.
The prenatal sex steroid theory also provides a framework to explore sex bias in other neurodevelopmental and psychiatric disorders, potentially explaining why some conditions disproportionately affect males or females. It compels researchers to question how hormonal modulation during development can set divergent trajectories for brain connectivity, cognitive processing, and behavior.
Emerging data further point to the interplay between prenatal hormones and immune function, epigenetic regulation, and metabolic pathways, opening multidisciplinary frontiers. The integration of hormonal data with systems biology approaches promises to unravel the intricate networks governing neurodevelopment and their perturbation in autism.
As research propels forward, ethical considerations regarding the interpretation and application of hormonal findings in autism must be front and center. The community must guard against reductionist narratives that oversimplify the rich neurodiversity embodied by autistic individuals, ensuring that scientific advances empower rather than stigmatize.
Ultimately, the 25-year journey of the prenatal sex steroid theory exemplifies the evolution of scientific inquiry—beginning with bold hypotheses, traversing complex empirical landscapes, and arriving at a more sophisticated, multi-dimensional comprehension of autism. It highlights the power of interdisciplinary collaboration and technological innovation in transforming our understanding of the human brain.
This milestone also serves as a clarion call for sustained investment in developmental neuroscience and endocrinology, essential for decoding the biological rhythms that orchestrate brain formation. The prenatal sex steroid theory, invigorated by fresh data and novel methodologies, is set to remain a cornerstone in the quest to unravel the enigma of autism spectrum conditions.
As autism research enters its next phase, the nuanced roles of prenatal sex steroids will likely illuminate new biomarkers for early detection, clarify mechanisms underlying sex differences, and pave the way for personalized interventions attuned to the hormonal and genetic profile of each individual. The coming decades promise a deeper grasp of how the earliest hormonal whispers can shape a lifetime of cognition and behavior.
Subject of Research: Prenatal sex steroid hormones and their role in autism spectrum development.
Article Title: The prenatal sex steroid theory of autism after 25 years.
Article References:
Baron-Cohen, S., Tsompanidis, A., Srivastava, D.P. et al. The prenatal sex steroid theory of autism after 25 years. Nat Hum Behav (2026). https://doi.org/10.1038/s41562-026-02437-0
Image Credits: AI Generated
